How to pay the least
From
$19.51 for 30 capsules delivered ($14.26 plus $5.25 shipping)
Generic rifampin from Cost Plus Drugs, by mail. Pick the strength on your label for its own price.
What to do
- Make a free account on costplusdrugs.com. Ask your prescriber to send the prescription there, or Cost Plus Drugs can transfer it.Open Cost Plus Drugs
- Order generic rifampin. It comes by mail.
Other ways
Need it today? From $23.82 for 30 capsules with the free Team Cuban Card, at pharmacies that take it. Get the free card and show it there.
See the price and get the cardEvery company’s rifampin is rated by the FDA to work the same, so any pharmacy can fill your prescription with the one it stocks.
Where to buy it
Pharmacies’ own cash prices for generic rifampin, lowest first.
Pick up in storeDelivered
- Delivered: Cost Plus Drugs from $14.26for 30 capsules150 mg $14.26 · 300 mg $15.35Plus $5.25 shipping
- Pick up in store: Team Cuban Card $23.82for 30 capsules300 mgFree card · Kroger, Albertsons, Safeway, Meijer and many local pharmaciesFind a pharmacy that takes it
- Pick up in store: Walgreens + Optum Perks $49.18for 60 capsules300 mgFree Optum Perks coupon · not with insuranceFind the nearest store
- Delivered: Amazon Pharmacy from $25.70for 30 capsules150 mg $90.50 · 300 mg $25.70Prime members only · $139 a year · Free delivery · Prime price: limits on some medicines if you're over 65 or have Medicare, Medicaid or TRICARE
- Pick up in store: Costco $54.99for 60 capsules300 mgMembers only · $65 a yearFind the nearest store
- Delivered: Optum Perks $83.50for 60 capsules300 mgPlus $5 shipping · Not with insurance
- Pick up in store: Sam's Club See its pricePlus members only · $120 a yearFind the nearest store
From each pharmacy’s own site, read November 17, 2026. Confirm the price before you fill.
About these prices
Prices change, can differ by store and state, and may depend on the strength and how many you take. With insurance, ask what your plan charges; it can be less.
Who makes it
4 companies sell rifampin in this form, each one rated by the FDA as a substitute for the others. A pharmacy fills whichever one it stocks. To get a certain maker, ask for it by name; most pharmacies can order it in a day or two.
-
ANI Pharmaceuticals150 mg, 300 mg
Has dyes: D&C Red No. 28, FD&C Blue No. 1, FD&C Red No. 40 · Made by Novitium Pharma
Product page on anipharmaceuticals.com
How it looks, what’s in it, NDCs
150 mg Dark red opaque cap and light red opaque body, capsule, 18 mm, marked “150mg / N892”
Package NDC Bottle of 30 70954-892-10 Bottle of 100 70954-892-20 300 mg Dark red opaque cap and light red opaque body, capsule, 19 mm, marked “300mg / N893”
Package NDC Bottle of 30 70954-893-10 Bottle of 60 70954-893-20 Bottle of 100 70954-893-30 Inactive ingredients: magnesium stearate, docusate sodium, sodium benzoate, starch, corn, talc, cellulose, microcrystalline, silicon dioxide, gelatin, water, sodium lauryl sulfate, titanium dioxide, FD&C Red No. 40, D&C Red No. 28, FD&C Blue No. 1, shellac, ferrosoferric oxide, potassium hydroxide, propylene glycol
-
Blu Pharmaceuticals150 mg, 300 mg
Has dyes: D&C Red No. 28, D&C Yellow No. 10, FD&C Blue No. 1, FD&C Blue No. 2, FD&C Red No. 40 · Made by Epic Pharma
How it looks, what’s in it, NDCs
150 mg Medium orange opaque body and cap, capsule, 18 mm, marked “E801”
Package NDC Bottle of 30 24658-801-30 300 mg Swedish orange opaque body and cap, capsule, 18 mm, marked “E799”
Package NDC Bottle of 60 24658-802-60 Inactive ingredients: silicon dioxide, starch, corn, D&C Yellow No. 10, docusate sodium, FD&C Blue No. 1, FD&C Blue No. 2, FD&C Red No. 40, gelatin, magnesium stearate, microcrystalline cellulose, sodium benzoate, propylene glycol, ferrosoferric oxide, talc, shellac, titanium dioxide, D&C Red No. 28
-
Epic Pharma150 mg, 300 mg
Has dyes: D&C Red No. 28, D&C Yellow No. 10, FD&C Blue No. 1, FD&C Blue No. 2, FD&C Red No. 40
Product page on epic-pharma.com
How it looks, what’s in it, NDCs
150 mg Medium orange opaque body and cap, capsule, 18 mm, marked “E801”
Package NDC Bottle of 30 42806-801-30 Bottle of 100 42806-801-01 300 mg Swedish orange opaque body and cap, capsule, 18 mm, marked “E799”
Package NDC Bottle of 30 42806-799-30 Bottle of 60 42806-799-60 Bottle of 100 42806-799-01 Bottle of 500 42806-799-05 Inactive ingredients: silicon dioxide, starch, corn, D&C Yellow No. 10, docusate sodium, FD&C Blue No. 1, FD&C Blue No. 2, FD&C Red No. 40, gelatin, magnesium stearate, microcrystalline cellulose, sodium benzoate, propylene glycol, ferrosoferric oxide, talc, shellac, titanium dioxide, D&C Red No. 28
-
Lupin Pharmaceuticals150 mg, 300 mg
Has dyes: D&C Red No. 28, FD&C Blue No. 1, FD&C Red No. 40
How it looks, what’s in it, NDCs
150 mg Dark Red and Light Red, capsule, 18 mm, marked “LU / E01”
Package NDC Bottle of 30 68180-658-06 300 mg Dark Red and Light Red, capsule, 19 mm, marked “LU / E02”
Package NDC Bottle of 30 68180-659-06 Bottle of 60 68180-659-07 Inactive ingredients: crospovidone (120 .mu.m), D&C Red No. 28, FD&C Blue No. 1, FD&C Red No. 40, gelatin, magnesium stearate, potassium hydroxide, propylene glycol, shellac, sodium lauryl sulfate, starch, corn, titanium dioxide
Who sells it: FDA and Medicaid records, updated weekly. Each maker’s page, card and program is from its own site.
What to say at the pharmacy
“Before you fill it, what would I pay for generic rifampin?”
Paying cash? Ask for the cash price. With insurance, ask what your plan charges.
What it’s used for
What the FDA label says
In the treatment of both tuberculosis and the meningococcal carrier state, the small number of resistant cells present within large populations of susceptible cells can rapidly become the predominant type. Bacteriologic cultures should be obtained before the start of therapy to confirm the susceptibility of the organism to rifampin and they should be repeated throughout therapy to monitor the response to treatment. Since resistance can emerge rapidly, susceptibility tests should be performed in the event of persistent positive cultures during the course of treatment. If test results show resistance to rifampin and the patient is not responding to therapy, the drug regimen should be modified.
Tuberculosis
Rifampin is indicated in the treatment of all forms of tuberculosis.
A three-drug regimen consisting of rifampin, isoniazid, and pyrazinamide (e.g., RIFATER® (Sanofi-aventis U.S. LLC)) is recommended in the initial phase of short-course therapy which is usually continued for 2 months. The Advisory Council for the Elimination of Tuberculosis, the American Thoracic Society, and Centers for Disease Control and Prevention recommend that either streptomycin or ethambutol be added as a fourth drug in a regimen containing isoniazid (INH), rifampin, and pyrazinamide for initial treatment of tuberculosis unless the likelihood of INH resistance is very low. The need for a fourth drug should be reassessed when the results of susceptibility testing are known. If community rates of INH resistance are currently less than 4%, an initial treatment regimen with less than four drugs may be considered.
Following the initial phase, treatment should be continued with rifampin and isoniazid for at least 4 months. Treatment should be continued for longer if the patient is still sputum or culture positive, if resistant organisms are present, or if the patient is HIV positive.
Rifampin IV is indicated for the initial treatment and retreatment of tuberculosis when the drug cannot be taken by mouth.
Meningococcal Carriers
Rifampin is indicated for the treatment of asymptomatic carriers of Neisseria meningitidis to eliminate meningococci from the nasopharynx. Rifampin is not indicated for the treatment of meningococcal infection because of the possibility of the rapid emergence of resistant organisms. (See WARNINGS.)
Rifampin should not be used indiscriminately, and, therefore, diagnostic laboratory procedures, including serotyping and susceptibility testing, should be performed for establishment of the carrier state and the correct treatment. So that the usefulness of rifampin in the treatment of asymptomatic meningococcal carriers is preserved, the drug should be used only when the risk of meningococcal disease is high.
To reduce the development of drug-resistant bacteria and maintain the effectiveness of rifampin and other antibacterial drugs, rifampin should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. When culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. In the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy.
Source: the FDA label for Rifampin (EPIC PHARMA, LLC), December 20, 2023. Full label on DailyMed
Good to know
- Different companies’ rifampin can look different. The FDA requires each to work the same way.
- Don’t stop or change a medicine without talking to your pharmacist or prescriber.
Prices checked November 17, 2026. Prices change: confirm with the pharmacy before you fill. drugalt.com/drug/rifampin/